Fig. 1.
Balovaptan mean plasma PK concentrations in Study NCT01418963 after once-daily administration of 12, 20, 40 or 52 mg balovaptan for 14 days in neurotypical adult participants
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.